New quality requirements for tobacco products
European Pharmaceutical Review
JUNE 8, 2023
9″ It will be interesting to see whether FDA tries to control carcinogenic TSNAs in tobacco products using an acceptable intake (AI) strategy, aligned with approaches applied to medicinal products for nitrosamines. This resulted in certain manufacturers exiting the market. The AIs for NNN and NNK are 96.0 Internet] NHS Digital.
59 
Let's personalize your content